SE8202172L - Topiska farmaceutiska kompositioner - Google Patents

Topiska farmaceutiska kompositioner

Info

Publication number
SE8202172L
SE8202172L SE8202172A SE8202172A SE8202172L SE 8202172 L SE8202172 L SE 8202172L SE 8202172 A SE8202172 A SE 8202172A SE 8202172 A SE8202172 A SE 8202172A SE 8202172 L SE8202172 L SE 8202172L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
topical pharmaceutical
skin
penetrable
difficultly
Prior art date
Application number
SE8202172A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
J Franz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2327/81A external-priority patent/CH653256A5/de
Priority claimed from CH2631/81A external-priority patent/CH647149A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8202172L publication Critical patent/SE8202172L/
Priority to IT2330082U priority Critical patent/IT8223300V0/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8202172A 1981-04-06 1982-09-10 Topiska farmaceutiska kompositioner SE8202172L (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT2330082U IT8223300V0 (it) 1982-04-29 1982-10-27 Serie di sei modelli di telai rigidi in tubolare metallico con piegature arcuate, combinabili con lamine o piani orizzontali e cuscini per comporre altrettanti mobili (quali tavoli, sedili, sgabelli, poltrone) adatti specialmente come arredamento da giardino o da campagna.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH2327/81A CH653256A5 (en) 1981-04-06 1981-04-06 Microemulsion for cutaneous use
CH2631/81A CH647149A5 (en) 1981-04-22 1981-04-22 Composition with 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole for cutaneous use
CH327881 1981-05-20

Publications (1)

Publication Number Publication Date
SE8202172L true SE8202172L (sv) 1982-10-07

Family

ID=27173625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8202172A SE8202172L (sv) 1981-04-06 1982-09-10 Topiska farmaceutiska kompositioner

Country Status (16)

Country Link
AU (1) AU564570B2 (fi)
CA (1) CA1192496A (fi)
DE (1) DE3212053A1 (fi)
DK (1) DK155882A (fi)
ES (1) ES511169A0 (fi)
FI (1) FI821123L (fi)
FR (1) FR2502951B1 (fi)
GB (2) GB2098865B (fi)
GR (1) GR75462B (fi)
IL (1) IL65424A0 (fi)
IT (1) IT8220611A0 (fi)
MY (1) MY8600571A (fi)
NL (1) NL8201413A (fi)
NZ (1) NZ200232A (fi)
PT (1) PT74703B (fi)
SE (1) SE8202172L (fi)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (fi) * 1982-10-07 1986-05-15
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
KR920010392B1 (ko) * 1984-03-01 1992-11-27 산도즈 아크리엔 게젤샤프트 경피투여용 약학 조성물의 제조방법
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4767625A (en) * 1985-09-02 1988-08-30 Kao Corporation Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same
US4690774A (en) 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
US4797272A (en) * 1985-11-15 1989-01-10 Eli Lilly And Company Water-in-oil microemulsions for cosmetic uses
DE3805744C2 (de) * 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
EP0580778B1 (en) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
WO1993011798A1 (en) * 1991-12-16 1993-06-24 Alza Corporation Improved formulations with hydrophobic permeation enhancers
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
JP3631490B2 (ja) 1992-05-13 2005-03-23 ノバルティス ファーマ株式会社 シクロスポリン含有眼科用組成物
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
EP0684832A4 (en) * 1993-02-17 1996-09-11 Smithkline Beecham Corp MICROEMULSIONS CONTAINING PHARMACEUTICAL COMPOSITIONS.
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
DE4442999A1 (de) * 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
EP0988046B1 (en) 1997-01-30 2004-09-15 Novartis AG Oil-free pharmaceutical compositions containing cyclosporin a
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
IN188719B (fi) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19825856A1 (de) * 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
BR9916063A (pt) 1998-12-11 2002-01-22 Pharmasolutions Inc Composições auto-emulsificantes para medicamentos fracamente solúveis em água
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CA2529528A1 (en) * 2003-06-20 2004-12-29 Ronald Aung-Din Topical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
ES2348303T3 (es) 2003-12-08 2010-12-02 Cpex Pharmaceuticals, Inc. Composiciones farmacauticas y procedimientos de tratamiento con insulina.
US7740875B2 (en) 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US9308203B2 (en) * 2008-10-01 2016-04-12 Taiwan Biotech Co., Ltd. Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH570401A5 (fi) * 1972-05-09 1975-12-15 Wander Ag Dr A
GB1559811A (en) * 1975-07-28 1980-01-30 Sandoz Ltd Pharmaceutically active benzothiadiazole derivatives
CH632268A5 (de) * 1977-01-14 1982-09-30 Sandoz Ag Verfahren zur herstellung von neuen heterocyclylaminoderivaten.

Also Published As

Publication number Publication date
MY8600571A (en) 1986-12-31
ES8308698A1 (es) 1983-10-01
NL8201413A (nl) 1982-11-01
AU564570B2 (en) 1987-08-20
PT74703A (en) 1982-05-01
NZ200232A (en) 1985-08-16
FR2502951A1 (fr) 1982-10-08
CA1192496A (en) 1985-08-27
FR2502951B1 (fr) 1985-12-06
PT74703B (en) 1984-05-30
GB2098865A (en) 1982-12-01
GB2098865B (en) 1985-12-18
DE3212053A1 (de) 1982-10-21
ES511169A0 (es) 1983-10-01
GB2148711A (en) 1985-06-05
AU8233482A (en) 1982-10-14
GR75462B (fi) 1984-07-20
IL65424A0 (en) 1982-07-30
FI821123A0 (fi) 1982-03-31
FI821123L (fi) 1982-10-07
GB2148711B (en) 1985-12-18
GB8408654D0 (en) 1984-05-16
DK155882A (da) 1982-12-10
IT8220611A0 (it) 1982-04-06

Similar Documents

Publication Publication Date Title
SE8202172L (sv) Topiska farmaceutiska kompositioner
ATE46080T1 (de) Pharmazeutische komposition.
KR870005637A (ko) 약물 데포
FI963424A (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
ES479271A1 (es) Un procedimiento para la preparacion de compuestos derivados de acido tioetianico.
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
NL193907B (nl) Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
DK0460062T3 (da) Huperzin A-analoger
NO166281C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,1-disubstituerte cyklopropanderivater.
DE3484904D1 (de) Arzneimittelzusammensetzungen ermaessigter toxizitaet.
IT7927614A0 (it) 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche.
GB2021409A (en) Pharmaceutical composition
IT8021550A0 (it) Derivati adenosinici ad attivita'antinfiammatoria ed analgesica e composizioni terapeutiche che licontengono come principio attivo.
SE8002642L (sv) Analgetiska och myotonolytiska preparat
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
SE7603223L (sv) 13,14-dehydro-11-deoxi-prostaglandiner och forfarande for deras framstellning
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
SE8704240L (sv) Analgetiska preparat
GR3004113T3 (fi)
EP0056681A3 (en) Levonantradol and n-methyllevonantradol formulations
GB1327560A (en) Effervescent pharmaceutical preparations
SE8800461D0 (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8202172-6

Effective date: 19880112

Format of ref document f/p: F